CRNX
Crinetics Pharmaceuticals, Inc.$83.94+0.23 (+0.27%)Prev Close$83.71·MCap$8.86B·P/E—·Vol2.68M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
16
$8.49M
◆
Net Activity
Net Seller
$8.49M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Crinetics Pharmaceuticals, Inc. (CRNX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 16 insider sales totaling $8.49M. The most recent insider transaction was by Vivaldi Coelho Rogerio (director), who sold $120.0K worth of shares on Jul 7, 2026. Crinetics Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.86B.
CRNX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Vivaldi Coelho Rogerio | director | Sell | 3,000 | $40.00 | $120.0K | 19,225 |
| Jun 18, 2026 | Okey Stephanie | director | Sell | 6,900 | $35.67 | $246.1K | 7,008-50% |
| Apr 10, 2026 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | Sell | 85,163 | $40.10 | $3.42M | 105,289-45% |
| Mar 18, 2026 | Betz Stephen F. | officer: Chief Scientific Officer | Sell | 10,612 | $37.37 | $396.6K | 141,342 |
| Mar 18, 2026 | Knight Jeff E. | officer: Chief Operating Officer | Sell | 9,911 | $37.37 | $370.4K | 115,979 |
| Mar 18, 2026 | Struthers Richard Scott | director, officer: President & CEO | Sell | 21,981 | $37.37 | $821.5K | 413,563 |
| Mar 13, 2026 | Vivaldi Coelho Rogerio | director | Sell | 5,000 | $36.15 | $180.8K | 16,823 |
| Jan 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 0 |
| Dec 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $45.02 | $225.1K | 0 |
| Nov 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $42.66 | $213.3K | 0 |
| Oct 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $41.81 | $209.1K | 0 |
| Sep 26, 2025 | Fust Matthew K | Director | Sell | 16,000 | $44.75 | $716.0K | 0 |
| Sep 26, 2025 | Struthers Richard Scott | President & CEO | Sell | 4,000 | $45.00 | $180.0K | 0 |
| Sep 2, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $32.10 | $160.5K | 0 |
| Aug 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 30,000 | $30.43 | $912.9K | 0 |
| Aug 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 6,492 | $29.18 | $189.4K | 0 |
| Jun 12, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 97,483 | $32.23 | $3.14M | 0 |
| Mar 19, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197.4K | 0 |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | 7,162 | $34.20 | $245.0K | 0 |
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 2,515 | $34.20 | $86.0K | 0 |
| Mar 19, 2025 | Struthers Richard Scott | President & CEO | Sell | 17,338 | $34.20 | $593.0K | 0 |
| Feb 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $39.07 | $195.3K | 0 |
| Jan 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,000 | $52.09 | $781.4K | 0 |
| Dec 2, 2024 | Struthers Richard Scott | President & CEO | Sell | 10,000 | $57.57 | $575.7K | 0 |
| Nov 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 501 | $56.52 | $28.3K | 0 |
| Oct 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $54.63 | $785.3K | 0 |
| Sep 26, 2024 | Wilson Marc | CFO | Sell | 25,000 | $51.11 | $1.28M | 0 |
| Sep 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53.3K | 0 |
| Aug 26, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159.6K | 0 |
| Aug 12, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143.0K | 0 |
| Jul 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160.3K | 0 |
| Jul 25, 2024 | Wilson Marc | CFO | Sell | 19,056 | $53.88 | $1.03M | 0 |
| Jul 15, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 27,000 | $55.00 | $1.49M | 0 |
| Jul 15, 2024 | Wilson Marc | CFO | Sell | 25,000 | $55.00 | $1.38M | 0 |
| Jul 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145.7K | 0 |
| Jul 5, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.08 | $661.2K | 0 |
| Jul 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.87 | $645.0K | 0 |
| Jun 28, 2024 | Wilson Marc | CFO | Sell | 32,129 | $43.61 | $1.40M | 0 |
| Jun 26, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 956 | $44.38 | $42.4K | 0 |
| Jun 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136.1K | 0 |
| Jun 24, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,500 | $45.73 | $434.4K | 0 |
| Jun 21, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.66 | $669.9K | 0 |
| Jun 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131.6K | 0 |
| May 28, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142.5K | 0 |
| May 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $49.43 | $148.3K | 0 |
| May 8, 2024 | Struthers Richard Scott | President & CEO | Sell | 107,448 | $49.40 | $5.31M | 0 |
| Apr 15, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.47 | $639.3K | 0 |
| Apr 4, 2024 | Struthers Richard Scott | President & CEO | Sell | 40,951 | $49.17 | $2.01M | 0 |
| Mar 28, 2024 | Okey Stephanie | Director | Sell | 17,500 | $46.38 | $811.6K | 0 |
| Mar 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 32,359 | $44.31 | $1.43M | 0 |
Showing 1–50 of 123
1 / 3
CRNX Insider Buying Activity
The following table shows recent insider purchases of Crinetics Pharmaceuticals, Inc. (CRNX) stock reported via SEC Form 4 filings.
No insider buying activity found for CRNX in the last 12 months.
CRNX Insider Selling Activity
The following table shows recent insider sales of Crinetics Pharmaceuticals, Inc. (CRNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Vivaldi Coelho Rogerio | director | Sell | 3,000 | $40.00 | $120.0K | 19,225 |
| Jun 18, 2026 | Okey Stephanie | director | Sell | 6,900 | $35.67 | $246.1K | 7,008-50% |
| Apr 10, 2026 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | Sell | 85,163 | $40.10 | $3.42M | 105,289-45% |
| Mar 18, 2026 | Betz Stephen F. | officer: Chief Scientific Officer | Sell | 10,612 | $37.37 | $396.6K | 141,342 |
| Mar 18, 2026 | Knight Jeff E. | officer: Chief Operating Officer | Sell | 9,911 | $37.37 | $370.4K | 115,979 |
| Mar 18, 2026 | Struthers Richard Scott | director, officer: President & CEO | Sell | 21,981 | $37.37 | $821.5K | 413,563 |
| Mar 13, 2026 | Vivaldi Coelho Rogerio | director | Sell | 5,000 | $36.15 | $180.8K | 16,823 |
| Jan 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | Sell | 2,500 | $55.00 | $137.5K | 0 |
| Dec 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $45.02 | $225.1K | 0 |
| Nov 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $42.66 | $213.3K | 0 |
| Oct 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $41.81 | $209.1K | 0 |
| Sep 26, 2025 | Fust Matthew K | Director | Sell | 16,000 | $44.75 | $716.0K | 0 |
| Sep 26, 2025 | Struthers Richard Scott | President & CEO | Sell | 4,000 | $45.00 | $180.0K | 0 |
| Sep 2, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $32.10 | $160.5K | 0 |
| Aug 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 30,000 | $30.43 | $912.9K | 0 |
| Aug 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 6,492 | $29.18 | $189.4K | 0 |
| Jun 12, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 97,483 | $32.23 | $3.14M | 0 |
| Mar 19, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197.4K | 0 |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | 7,162 | $34.20 | $245.0K | 0 |
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 2,515 | $34.20 | $86.0K | 0 |
| Mar 19, 2025 | Struthers Richard Scott | President & CEO | Sell | 17,338 | $34.20 | $593.0K | 0 |
| Feb 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 5,000 | $39.07 | $195.3K | 0 |
| Jan 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 15,000 | $52.09 | $781.4K | 0 |
| Dec 2, 2024 | Struthers Richard Scott | President & CEO | Sell | 10,000 | $57.57 | $575.7K | 0 |
| Nov 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 501 | $56.52 | $28.3K | 0 |
| Oct 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $54.63 | $785.3K | 0 |
| Sep 26, 2024 | Wilson Marc | CFO | Sell | 25,000 | $51.11 | $1.28M | 0 |
| Sep 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53.3K | 0 |
| Aug 26, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159.6K | 0 |
| Aug 12, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143.0K | 0 |
| Jul 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160.3K | 0 |
| Jul 25, 2024 | Wilson Marc | CFO | Sell | 19,056 | $53.88 | $1.03M | 0 |
| Jul 15, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 27,000 | $55.00 | $1.49M | 0 |
| Jul 15, 2024 | Wilson Marc | CFO | Sell | 25,000 | $55.00 | $1.38M | 0 |
| Jul 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145.7K | 0 |
| Jul 5, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.08 | $661.2K | 0 |
| Jul 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.87 | $645.0K | 0 |
| Jun 28, 2024 | Wilson Marc | CFO | Sell | 32,129 | $43.61 | $1.40M | 0 |
| Jun 26, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 956 | $44.38 | $42.4K | 0 |
| Jun 25, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136.1K | 0 |
| Jun 24, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 9,500 | $45.73 | $434.4K | 0 |
| Jun 21, 2024 | Hassard James | Chief Commercial Officer | Sell | 15,000 | $44.66 | $669.9K | 0 |
| Jun 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131.6K | 0 |
| May 28, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142.5K | 0 |
| May 10, 2024 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $49.43 | $148.3K | 0 |
| May 8, 2024 | Struthers Richard Scott | President & CEO | Sell | 107,448 | $49.40 | $5.31M | 0 |
| Apr 15, 2024 | Pizzuti Dana | Chief Med and Dev Officer | Sell | 14,375 | $44.47 | $639.3K | 0 |
| Apr 4, 2024 | Struthers Richard Scott | President & CEO | Sell | 40,951 | $49.17 | $2.01M | 0 |
| Mar 28, 2024 | Okey Stephanie | Director | Sell | 17,500 | $46.38 | $811.6K | 0 |
| Mar 22, 2024 | Knight Jeff E. | Chief Operating Officer | Sell | 32,359 | $44.31 | $1.43M | 0 |
CRNX Insiders
Similar Stocks to CRNX
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B